1. Home
  2. BMR vs GBIO Comparison

BMR vs GBIO Comparison

Compare BMR & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMR
  • GBIO
  • Stock Information
  • Founded
  • BMR 2009
  • GBIO 2016
  • Country
  • BMR Israel
  • GBIO United States
  • Employees
  • BMR N/A
  • GBIO N/A
  • Industry
  • BMR Computer Software: Prepackaged Software
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMR Technology
  • GBIO Health Care
  • Exchange
  • BMR Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • BMR 59.3M
  • GBIO 64.8M
  • IPO Year
  • BMR 2023
  • GBIO 2020
  • Fundamental
  • Price
  • BMR $2.90
  • GBIO $0.61
  • Analyst Decision
  • BMR
  • GBIO Strong Buy
  • Analyst Count
  • BMR 0
  • GBIO 2
  • Target Price
  • BMR N/A
  • GBIO $6.50
  • AVG Volume (30 Days)
  • BMR 225.7K
  • GBIO 453.7K
  • Earning Date
  • BMR 03-26-2025
  • GBIO 03-05-2025
  • Dividend Yield
  • BMR N/A
  • GBIO N/A
  • EPS Growth
  • BMR N/A
  • GBIO N/A
  • EPS
  • BMR N/A
  • GBIO N/A
  • Revenue
  • BMR $2,955,000.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • BMR $21.52
  • GBIO $212.74
  • Revenue Next Year
  • BMR N/A
  • GBIO N/A
  • P/E Ratio
  • BMR N/A
  • GBIO N/A
  • Revenue Growth
  • BMR 2.25
  • GBIO 514.08
  • 52 Week Low
  • BMR $2.40
  • GBIO $0.59
  • 52 Week High
  • BMR $10.25
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • BMR 34.17
  • GBIO 28.72
  • Support Level
  • BMR $3.17
  • GBIO $0.60
  • Resistance Level
  • BMR $3.65
  • GBIO $0.75
  • Average True Range (ATR)
  • BMR 0.23
  • GBIO 0.07
  • MACD
  • BMR -0.06
  • GBIO 0.00
  • Stochastic Oscillator
  • BMR 6.74
  • GBIO 9.63

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: